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Background: Tuberculosis is a disease that can involve every organ system. While pulmonary tuberculosis is the
most common presentation, extrapulmonary tuberculosis (EPT) is also an important clinical problem. The current
study aimed to outline and compare the demographic and clinical features of pulmonary and extrapulmonary
tuberculosis cases in adults.
Methods: Medical records of 411 patients (190 women, 221 men) treated between January 2010 and July 2014 in
provincial tuberculosis control dispensary was retrospectively reviewed. Demographic and clinical characteristics
were compared for pulmonary and extrapulmonary tuberculosis cases.
Results: Of these 411 cases, 208 (50.6 %) had pulmonary tuberculosis (PTB) and 203 were diagnosed with
extrapulmonary tuberculosis (EPTB) (49.4 %). The average ages for PTB and EPTB groups were 33.00-27.00 and
31.00-29.75, respectively (p = 0.513). Men were more frequently affected by PTB (59.6 %), while EPTB was more
commonly detected in women (52.2 %) (p = 0.016). Main diagnostic modalities for PTB were sputum/smear analyses
(72.7 %), clinical-radiological data (21.7 %) and biopsy (6.1 %); while biopsy (71.5 %), sputum/fluid analysis (18.8 %)
and clinical-radiological data (4.9 %) were used for confirming EPTB (p < 0.0019). The most common sites of EPTB
involvement were lymph nodes (39.4 %), followed by pleura (23.6 %), peritoneum (9.9 %) and bone (7.4 %).
Conclusıons: Extrapulmonary involvement of tuberculosis is common and females are more likely to be affected.
Increased clinical awareness is important since atypical presentations of the disease may constitute diagnostic and
therapeutic challenges.
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Tuberculosis (TB) is a chronic, granulomatous, bacterial
infection that may display multisystemic involvement. It
still constitutes a major global health problem and it is
estimated that almost one-third of the population is in-
fected worldwide [1, 2]. Main microbiological agent is
Mycobacterium tuberculosis in the vast majority of cases
[2]. The disease may transform into the active phase in
10 % of cases and lungs are the most common site of in-
volvement [1–3].
Pulmonary tuberculosis (PTB) is a highly contagious
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creativecommons.org/publicdomain/zero/1.0/infection [2, 3]. The proportion of PTB to EPTB var-
ies with respect to geographical, social, ethnic and
economical parameters [3]. The rate of extrapulmon-
ary tuberculosis (EPTB) patients in Turkey is esti-
mated as 39 %-45.1 % [1].
Owing to a functional immune system, the foci of
infection formed after the initial infection may be si-
lent in the beginning. However, the disease may be
reactivated at anytime and anywhere in the body [4].
This reactivation may be enhanced by the immune
compromisation and EPTB may become clinically
manifest in this setting [4, 5].
The most common sites for EPTB are lymph nodes,
pleura, cutaneous tissue, abdomen, gastrointestinal sys-
tem and bones [1, 3, 4]. Attributed to its atypical presen-
tation, diagnostic difficulties, increasing prevalence andcess article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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ical awareness for EPTB is crucial [2, 5]. Diagnosis
should be established immediately and treatment must
be started to reduce the morbidity and mortality due to
EPTB.
The current study was conveyed to outline and iden-
tify the demographic and clinical characteristics of PTB
and EPTB comparatively. Thereby, we hope to figure
out clinical clues may be determined for better recogni-
tion and more effective management of disease.
Material and methods
Study design
Medical records of the patients treated between January
2010 and July 2014 in provincial tuberculosis control
dispensary was retrospectively reviewed in accordance
with the principles of the Helsinki Declaration. Ethics
committee approval was obtained for this study. Demo-
graphic and clinical data were extracted from the med-
ical files of 411 cases diagnosed with active tuberculosis.
Age, gender, site of involvement, recurrence rate and
diagnostic methods were recorded and compared in
PTB and EPTB patients. Patients were divided age
groups as intervals of <21, 21-40, 41-60 and >60 years.
Diagnosis of PTB and EPTB are made in accordance
with definitions of World health Organization [6]. Pul-
monary tuberculosis was ruled in if two or three initial
sputum analyses were positive for acid-fast bacilli (AFB)
or one sputum smear positive for AFB in conjunction
with clinical and radiological data consistent with tuber-
culosis. Diagnosis of EFTB was established if fine needle
aspiration biopsy or biochemical analyses of pleural/
ascetic or other fluid samples or other histopathological
examinations yielded relevant results.
Exclusion criteria consisted of immune deficiency,
usage of immunosuppressive medications, simultaneous
pulmonary and extrapulmonary involvement by TB and
age < 15.
Statistical analysis
Analysis of data was made via the IBM Statistical Pack-






<21 16 (37 %) 28 (63 %) 0.0
21-40 51 (55 %) 42 (45 %)
41-60 25 (57 %) 19 (43 %)
>60 14 (58 %) 10 (42 %)
* statistically significantconformability of the data to the normal distribution
was tested with Kolmogorov-Smirnov test. Parameters
that display normal distribution were evaluated with
parametric methods, whereas variables without a normal
distribution were assessed by non-parametric methods.
Mann-Whitney U test was used to compare 2 independ-
ent groups and comparison of categorical variables was
carried out using Pearson’s chi-squared test exact
method. Since age variable did not exhibit normal distri-
bution, it was expressed as median-interquartile range.
Confidence interval was set at 95 % and level of statis-
tical significance was set at p <0.05.
Results
The whole study population consisted of 203 (49.4 %)
EPTB and 208 (50.6 %) PTB patients. The median-
interquartile ranges for PTB and EPTB groups were
33.00-27.00 and 31.00-29.75, respectively. Two groups
were similar in terms of age distribution (p = 0.513).
Analysis of data after allocation of cases in age groups
as intervals of <21, 21-40, 41-60 and >60 years was
made. In EPTB group, males were more frequently af-
fected in patients younger than 21 years and females
were more commonly involved in the other three age
groups (p = 0.034). In contrast, women were more likely
to be susceptible in patients <21 years and men were
predominantly affected in the remaining 3 age groups in
PTB (p = 0.007) (Table 1).
Women were more commonly affected by EPTB
(106/203; 52.2 %), while men (124/208; 59.6 %) were
predominantly involved in PTB group (p = 0.016).
Rate of recurrence and number of patients re-
admitting after interruption of treatment was similar
in two groups (p = 0.172 and p = 0.97). Diagnostic mo-
dality used for confirmation of TB was different in
two groups: For EPTB group, biopsy was the main
mode (71.5 %) followed by sputum/smear analyses
[18.8 %], for PTB group whereas sputum/smear ana-
lyses was the most frequent method (72.7 %) suc-
ceeded by clinical and radiological diagnosis (21.7 %)
(p < 0.001). Positivity for BCG scar was similar in
both PTB and EPTB groups (p = 0.491). Overview ofValue PTB p Value
Female Male
(n,%) (n,%)
34* 22 (58 %) 16 (42 %) 0.007*
33 (38 %) 54 (62 %)
11 (23 %) 36 (77 %)
18 (50 %) 18 (50 %)
Table 2 Comparison of parameters under investigation in PTB and EPTB groups
Variable EPTB PTB p Value
Age (years) <21 42 (20 %) 38 (18.2 %) 0.513
21-40 93 (45.8 %) 87 (41.8 %)
41-60 44 (24.6 %) 47 (22.5 %)
>60 24 (11.8 %) 36 (15.8 %)
Gender Female (n, %) 106 (52.2 %) 84 (40.4 %) 0.016*
Male (n,%) 97 (47.8 %) 124 (59.6 %)
Recurrence rate (n,%) 4 (1.97 %) 9 (4.26 %) 0.172
Re-admission after interruption of treatment 3 (1.48 %) 3 (1.44 %) 0.97
Presence of BCG scar 123 (59.6 %) 117 (56.3 %) 0.491
Most common modes of diagnosis Biopsy (n,%) 103 (71.5 %) 11 (6.1 %) <0.001*
Smear (n,%) 27 (18.8 %) 129 (72.7 %)
C&R clues (n,%) 7 (4.9 %) 39 (21.7 %)
*: statistically significant; EPTB extrapulmonary tuberculosis, PTB pulmonary tuberculosis, C&R clinical and radiological
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(Table 2).
The most common sites were lymph nodes (39.4 %),
pleura (23.6 %), peritoneum (9.9 %) and bone (7.4 %)
(Table 3).
The most common systemic disorders accompanying
EPTB were DM (n = 9; 0.04 %) and chronic renal failure
(n = 8; 0.04 %), while chronic renal failure (n = 9; 0.04)
and chronic obstructive pulmonary disease (n = 6;
0.03 %) were those detected frequently in PTB group.
Systemic diseases detected in PTB and EPTB groups are
shown in (Table 4).
Discussion
In this study, we aimed to investigate and compare the
demographic and clinical characteristics of EPTB and
PTB. Our results indicated that EPTB is almost as com-
mon as PTB and it is more likely to affect women.
Moreover, both PTB and EPTB appear as diseases affect-
ing young adults in provincial tuberculosis control
dispensary.Table 3 Sites of involvement in EPTB
Site Number (%)
Lymph nodes 80 (39.4 %)
Pleura 48 (23.6 %)
Peritoneum 20 (9.9 %)
Bone 15 (7.4 %)
Meninges 11 (5.4 %)
Urinary system 11 (5.4 %)
Breast 7 (3.4 %)
Pericardium 4 (2 %)
Other sites (GI tract, eye, etc.) 7 (3.4 %)
EPTB extrapulmonary tuberculosis, GI gastrointestinalThe incidence of EPTB was remarkably high (49.4 %)
in the present study. The most common sites of involve-
ment were lymph nodes, pleura, peritoneum and bone.
Interestingly, men were more likely be affected by PTB
and women were more prone to EPTB. Biopsy was the
most useful mode of diagnosis in EPTB, while sputum/
smear analyses was the most commonly used diagnostic
tool for PTB.
Earlier studies performed in different regions of
Turkey showed that the rates of EPTB cases among all
TB cases ranged from 3.2 % to 53.8 % [7–11]. The predi-
lection of EPTB for women may be linked with the lim-
ited facilities for access to healthcare and prevalence of
other risk factors such as smoking habit [2, 5]. Smoking
is less common in women and this may be one of the
factors responsible for the difference in distribution.
Moreover, Lam et al. have reported that the risk of mor-
tality increased with smoking in men, but not in women
[4, 12]. These results imply that females may be rela-
tively protected against the hazardous pulmonary effects
of smoking. In contrary, PTB was encountered moreTable 4 Systemic diseases encountered in EPTB and PTB
patients
Systemic disease Group
EPTB (number, %) PTB (number, %)
Diabetes mellitus 9 (0.04 %) 2 (0.01 %)
Chronic renal failure 8 (0.04 %) 9 (0.04 %)
COPD 3 (0.01 %) 6 (0.03 %)
Hypertension 3 (0.01 %) 4 (0.02 %)
Congestive heart failure 3 (0.01 %) 2 (0.01 %)
Lymphoma 3 (0.01 %) 1 (<0.01 %)
HIV positivity - 1 (<0.01 %)
EPTB extrapulmonary tuberculosis, PTB pulmonary tuberculosis, COPD chronic
obstructive pulmonary disease
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smoking among men in Turkey may be responsible for
this finding. However several studies investigated the im-
pact of gender on the occurrence of EPTB and found
that women were more likely to present their active TB
as EPTB [13–15].
We observed that young adult population was affected
by PTB and EPTB. However, Musellim et al. have re-
ported that age was not associated with EPTB [4]. In the
past decade, some cohort studies have reported an in-
creased percentage of EPTB in patients with TB [13, 14].
Even though TB is expected to arise more commonly in
older population with deterioration of immune system,
this finding reminds that control programs must be fo-
cussed especially on young population. Campaigns and
efforts must be directed to increase public awareness on
this topic to combat with contagion of TB.
Similar to most of the other publications, lymph nodes
were the most common sites involved in EPTB [1, 2, 5].
Controversially, Yang et al. have reported that bone and
joints were involved more commonly in EPTB [16],
while another study suggested that genitourinary system
and skin were affected more often than lymph nodes in
EPTB [17]. These variations may be linked with social or
environmental factors . In our series, peritoneal involve-
ment was the third most frequent site for EPTB group
in our series.
Pulmonary tuberculosis may present as atypical pneu-
monia, pleuritis, or upper lobe involvement. It may
present in an atypical fashion in case it is associated with
HIV [4].
Even though sputum/smear analysis and clinical/radio-
logical clues are mostly beneficial in PTB; biopsy and
histopathological diagnosis is usually required for ruling
in EPTB [2, 3]. Increased clinical awareness must be
followed by choice of appropriate diagnostic method
in order to make the diagnosis timely. It must be re-
membered that M. tuberculosis culture is the gold
standard for establishing the definitive diagnosis [5].
However, rates of culture positivity are far less than
expected not only in PTB cases but also in EPTB
group [5]. This circumstance may ensource from limi-
tations of technical facilities. Therefore, other diag-
nostic modes such as biopsy, sputum/smear analysis
and clinical-histopathological data may compensate
for the aforementioned restrictions attributed to cul-
ture results.
In the literature, risk factors for EPTB were female
gender in Asian and North African population, age
for sub-Saharan African people and HIV infection in
Europe [18]. These risk factors may show variability
in different populations and the characteristics of
EPTB need to be studied in multicentric studies on
larger populations.Some restrictions of the current study must be men-
tioned. This study was performed on a small sample size
with a retrospective design including only adult patients.
In addition, impacts of social, ethnic, economic and
environmental factors must be taken into account dur-
ing extrapolation of our results to larger populations.
Owing to the retrospective design, some critical data
such as nutritional status, microbial factors and habits
such as smoking and alcohol consumption may not be
fully achieved from the medical files.
In conclusion, EPTB is a frequent manifestation of TB
which has substantial morbidity. Despite atypical fea-
tures at presentation, diagnosis must be made without
delay and appropriate treatment must be started as soon
as possible for reduction of morbidity and mortality
rates. Tuberculosis control programs must be targeted at
specific populations under risk with special care on
young and female populations.
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